GAMBARDELLA, MARIA LUISA
 Distribuzione geografica
Continente #
AS - Asia 125
NA - Nord America 50
EU - Europa 43
SA - Sud America 5
Totale 223
Nazione #
SG - Singapore 96
US - Stati Uniti d'America 45
IT - Italia 29
HK - Hong Kong 14
CN - Cina 6
BR - Brasile 5
MX - Messico 5
BD - Bangladesh 3
AT - Austria 2
DE - Germania 2
FR - Francia 2
GB - Regno Unito 2
IN - India 2
NL - Olanda 2
VN - Vietnam 2
CZ - Repubblica Ceca 1
ES - Italia 1
FI - Finlandia 1
IL - Israele 1
PK - Pakistan 1
SE - Svezia 1
Totale 223
Città #
Singapore 67
Hong Kong 14
Catanzaro 9
Santa Clara 5
Mexico City 4
Seattle 4
San Maurizio Canavese 3
Chandler 2
Cirié 2
Dhaka 2
Hangzhou 2
Vienna 2
Ahmedabad 1
Akron 1
Ashburn 1
Atlanta 1
Boston 1
Chicago 1
Dallas 1
Hanoi 1
Helsinki 1
Ho Chi Minh City 1
Irati 1
Iúna 1
Lawrence 1
London 1
Milan 1
Mumbai 1
Munich 1
Nashua 1
Nova Iguaçu 1
Olomouc 1
Palermo 1
Philadelphia 1
Plano 1
Princeton 1
Ribeirão Preto 1
Senhor do Bonfim 1
Shanghai 1
Taranto 1
Utrecht 1
Wilmington 1
Wuhan 1
Totale 147
Nome #
Management of psychogenic non-epileptic seizures: a multidisciplinary approach 149
Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease 18
Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study 17
The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation 13
Portal hypertension-associated gastric pathology: role of endoscopic banding ligation 10
Use of Non-Invasive Biomarkers and Clinical Scores to Predict the Complications of Liver Cirrhosis: A Bicentric Experience 10
The levels of inflammatory, angiogenic, and stress biomarkers in plasma of donors depending on anti-SARS-CoV-2 IgG titers 8
Metabolic Dysfunction-Associated Steatotic Liver Disease vs. Metabolic Dysfunction-Associated Fatty Liver Disease: Which Option is the Better Choice? 5
Preventive and Therapeutic Effects of Baicalein, Galangin, and Isorhamnetin in Chronic Liver Diseases: A Narrative Review 5
Totale 235
Categoria #
all - tutte 1.404
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.404


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 2 0 0 0 1 0 0 0 0 0
2021/20223 0 0 0 1 0 0 0 1 0 1 0 0
2022/202314 2 0 1 0 0 1 0 1 4 2 3 0
2023/202411 1 1 7 1 0 0 0 0 0 0 1 0
2024/2025186 1 4 22 23 19 33 29 7 0 2 6 40
2025/202618 18 0 0 0 0 0 0 0 0 0 0 0
Totale 235